Human BACE-1 in complex with 3-(ethylamino)-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)phenyl)methyl)amino)propyl)-5-(2-oxo-1-pyrrolidinyl)benzamide
B. Clarke, G. Wayne, Rosalie Matico(GlaxoSmithKline (United States)), Julie A. Hawkins(Charles River Laboratories (United Kingdom)), J. Mosley(GlaxoSmithKline (United Kingdom)), Sharon Sweitzer(GlaxoSmithKline (United States)), David Riddell(Eli Lilly (United States)), Alexander G. O’Brien(Scripps Research Institute), Sally Redshaw(GlaxoSmithKline (United Kingdom)), Steven J. Stanway(GlaxoSmithKline (United Kingdom)), V. Soleil(GlaxoSmithKline (United Kingdom)), David T. MacPherson(GlaxoSmithKline (United Kingdom)), A. Naylor, G. Maile(GlaxoSmithKline (United Kingdom)), Kevin M. Smith(Louisiana State University), P. Theobald, D. Vesey(GlaxoSmithKline (United Kingdom)), J. Ward, R. Dunsdon(GlaxoSmithKline (United Kingdom)), Paul Rowland(GlaxoSmithKline (United Kingdom)), Izhar Hussain, Geoffrey Stemp(GlaxoSmithKline (United Kingdom)), C. Dingwall, D.S. Walter, Phillip J. Milner(Cornell University), Andrew Faller(GlaxoSmithKline (United Kingdom)), Emmanuel H. Demont(Age UK)
Cited by 0
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351
Radical CH Functionalization of Heteroarenes under Electrochemical Control
|Angewandte Chemie International Edition|2014|341
Compartmentalization of β-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts
|Current Biology|2001|302